Zobrazeno 1 - 10
of 98
pro vyhledávání: '"Om Dutt"'
Publikováno v:
Tecnología en Marcha, Vol 13, Iss 5 (2019)
Tecnología desarrollada entre 1988 y 1992 por medio de un proyecto de investigación conjunto entre el Instituto Tecnológico de Costa Rica y el National Research Council del Canadá. Se trata de una lámina corrugada para techo, fabricada con mater
Externí odkaz:
https://doaj.org/article/327ed27c850347c3879523a33e2e9440
Autor:
Kumar, Lalit, Hussain, Mohammad Mir, Chethan, Rajegowda, Sahoo, Ranjit Kumar, Malik, Prabhat S., Sharma, Om Dutt, Mathew, Anisha, Jha, Ankit, Gupta, Ritu, Sharma, Atul, Biswas, Ahitagni, Kumar, Rakesh, Thulkar, Sanjay, Malik, Soumyaranjan, Dutt, Ashish
Publikováno v:
In Clinical Lymphoma, Myeloma and Leukemia September 2022 22(9):e826-e835
Autor:
Kaur, Gurvinder, Gupta, Ritu, Mathur, Nitin, Rani, Lata, Kumar, Lalit, Sharma, Atul, Singh, Vishwajeet, Gupta, Anubha, Sharma, Om Dutt
Publikováno v:
In Leukemia Research January 2019 76:58-64
Autor:
Gupta, Ritu, Dahiya, Meetu, Kumar, Lalit, Shekhar, Varun, Sharma, Atul, Ramakrishnan, Lakshmy, Sharma, Om Dutt, Begum, Abida
Publikováno v:
In Clinical Lymphoma, Myeloma and Leukemia September 2018 18(9):e345-e350
Autor:
Nupur Das, Meetu Dahiya, Ritu Gupta, Lalit Kumar, Lata Rani, Anubha Gupta, Akanksha Farswan, Atul Sharma, Om Dutt Sharma
Publikováno v:
American Journal of Clinical Pathology. 159:69-80
Objectives With a substantial number of patients with multiple myeloma (MM) experiencing disease relapse, the quest for more sensitive methods to assess deeper responses indicative of cure continues. Methods In this prospective analysis of 170 patien
Autor:
Lalit Kumar, Mohammad Mir Hussain, Rajegowda Chethan, Ranjit Kumar Sahoo, Prabhat S. Malik, Om Dutt Sharma, Anisha Mathew, Ankit Jha, Ritu Gupta, Atul Sharma, Ahitagni Biswas, Rakesh Kumar, Sanjay Thulkar, Soumyaranjan Malik, Ashish Dutt
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:e826-e835
Autologous stem cell transplant (ASCT) is a standard therapy for transplant eligible patients of multiple myeloma (MM). To evaluate impact of time to transplant on subsequent outcomes, we analyzed data on consecutive MM patients who received novel ag
Autor:
Lalit, Kumar, Ranjit Kumar, Sahoo, Sudhir, Kumar, Annie K, Baa, Ghazal, Tansir, Neha, Pathak, Prabhat S, Malik, Om Dutt, Sharma, Anisha, Mathew, Ankit, Jha, Ritu, Gupta, Atul, Sharma, Ahitagni, Biswas, Rakesh, Kumar, Sanjay, Thulkar, Soumyaranjan, Malik, Ashish, Dutt
Publikováno v:
Leukemialymphoma.
We evaluated impact of melphalan dose on transplant outcomes for multiple myeloma. Between 1995 and 2019 459 consecutive patients received a transplant; 69(15%) received melphalan ≤150 mg/m2 (Mel 150 cohort) and 390 (85%) melphalan 200 mg/m2 (MEL 2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Bhaskar, Archana, Gupta, Ritu, Sreenivas, Vishnubatla, Rani, Lata, Kumar, Lalit, Sharma, Atul, Sharma, Om Dutt, Sharma, Mehar Chand, Thakur, Sonu Chand
Publikováno v:
In Leukemia Research April 2013 37(4):410-415